Groningen

• A study to test the efficacy and safety of SAR442970 in adults with hidradenitis suppurativa Ended
  2022-502370-17-00 4 2023-11-14 Hidradenitis suppurativa
• A study to test whether spesolimab helps people with a skin disease called hidradenitis suppurativa Ended
  2022-501074-19-00 10 2023-10-13 Hidradenitis suppurativa
• A controlled, randomized, first-in-human study of AP31969 investigating single and multiple ascending doses and the effect of food in health … Ended
  2023-505424-57-00 1 2023-10-04 Atrial Fibrillation (cardiac arrhythmia)
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Zosurabalpin following Intravenous Administration in Healthy Partic … Ended
  2023-505411-20-00 1 2023-09-20 There is no medical condition being investigated. This is a safety and
• Oral fluorescent tracer administration to detect of early esophageal adenocarcinomas Ended
  2023-503801-12-00 4 2023-09-15 Barrett's esophagus
• A Translational Phase 1B, 2-Part Study to Evaluate Pharmacokinetics, Safety and Pharmacodynamics of Treatment with ATX-304 Na Salt Tablets. Ended
  2023-505967-36-00 3 2023-09-15 Obesity with prediabetes or type 2 diabetes mellitus
• A randomized, parallel-group, double-blind, placebo-controlled, multicenter Phase III trial to evaluate efficacy and safety of secukinumab a … Ended
  2022-501895-25-00 5 2023-09-13 Polymyalgia Rheumatica
• A PHASE 1 STUDY TO ASSESS THE EXCRETION BALANCE, PHARMACOKINETICS, AND METABOLISM OF [14C] DC 806 IN HEALTHY MALE PARTICIPANTS. Ended
  2023-505367-36-00 3 2023-08-24 Healthy
• PREPARE-iVAC Ended
  2023-503894-39-00 11 2023-08-22 kidney transplantation
• A Phase 1, Randomized, Double-Blind, Placebo and Positive-Controlled Crossover Study to Evaluate the Effect of Clinical and Supraclinical Do … Ended
  2023-504310-30-00 3 2023-08-16 Healthy volunteers
• A PHASE 1, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE ASCENDING DOSE AND MULTIPLE ASCENDING DOSE ESCALATION STUDY OF THE SAFETY, TOLERABILITY, P … Ended
  2023-503866-22-00 1 2023-08-11 metabolic bone diseases
• A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 as single-agent and combination therapy in subjects with i … Ended
  2023-508267-69-00 3 2023-08-11 Subjects with Aadvanced solid tumors for whom life-prolonging therapie
• A study in healthy men to test how BI 1810631 is taken up and processed by the body. Ended
  2022-503047-17-00 3 2023-08-10 Healthy
• A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients with Chronic Obstructive Pulmonary Disease Ended
  2022-502234-70-00 5 2023-07-14 Chronic Obstructive Pulmonary Disease (COPD)
• An open-label, single-dose phase 1 study to evaluate the Absorption, Metabolism, and Excretion of [14C]-AZ-3102 in Healthy Male Subjects Ended
  2023-504916-14-00 3 2023-07-13 Glycosphingolipid lysosomal storage disorders
• A PHASE 1 STUDY TO ASSESS THE MASS BALANCE, PHARMACOKINETICS, AND METABOLISM OF ORAL [14C]-ZIPALERTINIB IN HEALTHY ADULT MALE SUBJECTS Ended
  2023-505085-28-00 3 2023-07-05 Cancer
• ARTEMIS: A Phase 3 Study of Ravulizumab to Protect Patients with Chronic Kidney Disease (CKD) from Cardiac Surgery Associated Acute Kidney … Ended
  2022-501802-36-00 5 2023-06-16 Prevention of cardiac surgery associated acute kidney injury
• A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (S … Ended
  2022-501752-29-00 5 2023-06-15 Hidradenitis Suppurativa
• A clinical trial in healthy people to look at how the body processes RO7268489 over time and when taken before or after a meal Ended
  2023-503528-25-00 3 2023-06-09 There is no medical condition being investigated. This is a pharmacoki
• A study in healthy male adult participants to assess how much test medicine (SAR443820) is taken up, broken down and removed by the body whe … Ended
  2022-502534-23-00 9 2023-06-02 amyotrophic lateral sclerosis (ALS)
• A single and multiple ascending dose study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZP-3813, a gr … Ended
  2023-503734-47-00 1 2023-05-26 Acromegaly
• A Randomized, Open-label, Single Dose, 3-Period, 6-Sequence Cross-Over Trial to Investigate the Relative Bioavailability of Apraglutide Vers … Ended
  2023-504430-22-00 2 2023-05-23 Healthy
• A research study to look at how a new medicine called NNC6019-0001 works and how safe it is for people who have heart disease due to TTR amy … Ended
  2023-506824-96-00 4 2023-05-23 The present study will include a population of patients with establish
• Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) in Combination with Topical Corticosteroids and/or Topical … Ended
  2022-501585-22-00 5 2023-05-11 Atopic Dermatitis

Showing 577–600 of 679 trials